Chondrial Therapeutics LLC was the first commercial funded entity by the Hamilton/Finneran Family.  The purpose is to utilize a proprietary protein replacement therapy as a treatment for Friedreich's Ataxia.  Eventually this delivery mechanism can be utilized for other mitochondrial diseases. Tom Hamilton has partnered with Doctors at the University of Indiana and former Eli Lilly Executives to push this critical therapy forward.  Our passion for solutions is only matched by our sense of urgency.